Cargando…
Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors
BACKGROUND: Hidradenitis suppurativa (HS) is an independent risk factor for the development of subclinical atherosclerosis. Tumour necrosis factor (TNF) inhibitors are effective for the treatment of recalcitrant moderate‐to‐severe HS. However, the effect of treatment with TNF inhibitors on subclinic...
Autores principales: | Oba, Muazzez Cigdem, Askin, Ozge, Gunver, Mehmet Guven, Kocaarslan, Gokce, Alis, Deniz Can, Engin, Burhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155849/ https://www.ncbi.nlm.nih.gov/pubmed/36973990 http://dx.doi.org/10.1111/srt.13302 |
Ejemplares similares
-
TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019) -
Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy
por: Lowe, Margaret M., et al.
Publicado: (2020) -
Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy
por: Lowe, Margaret M., et al.
Publicado: (2022) -
Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010) -
Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)